Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?

Source: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-22-28-2026
Scope: Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop
Family: Ranking Top 10
Observed: June 22–28, 2026 (2026-06-22/2026-06-28)
Published: June 28, 2026
Method — How readings are scoped: https://theobservatory.io/method#standards
Method — Run metadata: https://theobservatory.io/method/panel#run-metadata
Method — Source protocol: https://theobservatory.io/method#source-protocol
Method — Corrections and right of reply: https://theobservatory.io/method#corrections
Public table: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-22-28-2026/data.csv
Citation text: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-22-28-2026/citation.txt
Reuse terms: https://theobservatory.io/terms

us-uk.bookimed.com holds the rank-1 position on the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Seoul across 6 comparable scheduled runs in the observation period June 22–28, 2026, recording 11.56% AI opening share on this market.

Key facts:
• us-uk.bookimed.com: 12% AI opening share · opening in 6/6 runs
• seouldermatologyclinic.com: 11% AI opening share · opening in 5/6 runs
• seoulskinclinicforforeigners.com: 10% AI opening share · opening in 6/6 runs

Published table — AIO opening control — top 10 (June 22–28, 2026 · 80 queries per run · 6 comparable runs): Rank · Actor · AIO opening control
1. us-uk.bookimed.com — 11.56% AI opening share · opening in 6/6 runs — #1
2. seouldermatologyclinic.com — 10.55% AI opening share · opening in 5/6 runs — #2
3. seoulskinclinicforforeigners.com — 9.55% AI opening share · opening in 6/6 runs — #3
4. reddit.com — 9.05% AI opening share · opening in 6/6 runs — #4
5. seoulcosmeticsurgery.com — 8.54% AI opening share · opening in 6/6 runs — #5
6. youtube.com — 7.54% AI opening share · opening in 6/6 runs — #6
7. jivaka.kr — 7.04% AI opening share · opening in 5/6 runs — #7
8. enlienjang.com — 6.53% AI opening share · opening in 5/6 runs — #8
9. gangnamwomenshealth.com — 6.53% AI opening share · opening in 5/6 runs — #9
10. instagram.com — 6.53% AI opening share · opening in 4/6 runs — #10

Reading basis: This card observes the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Seoul in South Korea on Google desktop across 6 comparable scheduled runs in the observation period June 22–28, 2026. The panel ranks the top-10 actors by cumulative AI opening volume over the period, aggregated from 80 observed queries. Per-actor AI opening share uses one single period-wide denominator. AI Overview opening-control evidence was available on 6 of 6 runs in the comparable window.

Limitations and non-claims:
— Observes the observed AI answer surface only; within a defined scope and window.
— A period aggregate (6 comparable runs) — not a claim about bookings, revenue, or market share.
— Scoped to Luxury Medical Aesthetic Clinics Seoul Seoul, June 2026; not generalisable beyond this market and window.

— The Observatory · Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop · June 22–28, 2026
Based on governed AAI Kernel evidence. Capture identifier: pr_1791394754043_mkj23b. Cite freely with attribution. Published by The Observatory.
Source footnote: Sourced from a published AAI MIB card. The Observatory publishes this card’s public findings; values are as observed on the search surface, not business-market claims.
Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system
Cite: According to The Observatory (June 28, 2026), Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?. https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-june-22-28-2026

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date.
Revision: c48f6888c6464930